TITLE

readers respond

AUTHOR(S)
Maddy, Paul; Brumble, Sharon; Fisher, J.
PUB. DATE
July 2005
SOURCE
PN;Jul2005, Vol. 59 Issue 7, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Letter
ABSTRACT
Presents letters to the editor related to articles and issues, published in different editions of the journal "Paraplegia News." Information on stem-cell research; Reference to the article "Cathing Alternative," published in the March 2005 issue; Appreciation of the journal by a veteran having multiple sclerosis.
ACCESSION #
17324459

 

Related Articles

  • inbox. Kish, Carrie; Olszyk, Steve; Taylor, Lynn; Weigle, Pat; Daetsch, Rosemary; Searfoss, Kristin; Hall, Tana; Hicks, Ursula; Chesley, Stephanie; McCagg, Todd // Inside MS;Aug/Sep2006, Vol. 24 Issue 4, p13 

    Several letters to the editor are presented in response to articles in the April-May 2006 issue including "How I Cope With Progressive MS," by Julia Graham, "Clay Walker Talking" and "Living With an MS Bladder."

  • Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mancardi, Giovanni Luigi; Murialdo, Alessandra; Rossi, Paolo; Gualandi, Francesca; Martino, Gianvito; Marmont, Alberto; Ciceri, Fabio; Schenone, Angelo; Parodi, Roberto Carlo; Capello, Elisabetta; Comi, Giancarlo; Uccelli, Antonio // Multiple Sclerosis (13524585);Jun2005, Vol. 11 Issue 3, p367 

    Malignant forms of multiple sclerosis (MS) represent a limited group of very aggressive demyelinating diseases, which rapidly progress to severe disability leading often to life-threatening conditions. On these clinical entities, currently available therapies for MS are not very effective....

  • Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells. Rivera, Francisco J.; Kraus, J�rg; Steffenhagen, Carolin; K�ry, Patrick; Weidner, Norbert; Aigner, Ludwig // Current Signal Transduction Therapy;Sep2011, Vol. 6 Issue 3, p293 

    Multiple sclerosis (MS) is a demyelinating immune-mediated disease of the central nervous system (CNS). It is the most common cause of acquired disability in young adults and affects over 2 Mio people worldwide. Current treatments target primarily the immune system, reduce the relapse rate and...

  • Insight into Multiple Sclerosis. Wehman-Tubbs, Kelli; Yale, Steven H.; Rolak, Loren A. // Clinical Medicine & Research;Feb2005, Vol. 3 Issue 1, p41 

    Presents information on multiple sclerosis. Knowledge of the pathogenesis of multiple sclerosis; Definition of the most common presentation for patients with multiple sclerosis; Tests available to assist in the diagnosis of multiple sclerosis.

  • The Lesions of Multiple Sclerosis. Paty, Donald W.; Arnold, Douglas L. // New England Journal of Medicine;1/17/2002, Vol. 346 Issue 3, p199 

    Editorial. Discusses multiple sclerosis (MS). Reference to reports by Chang and colleagues and by Brex et al in this issue; How the findings are important to an understanding of the remyelination of lesions of MS and imply that transplantation of oligodendrocyte precursor cells will probably not...

  • American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Kim, E; Cameron, M; Lovera, J; Schaben, L; Bourdette, D; Whitham, R // Multiple Sclerosis Journal;Dec2011, Vol. 17 Issue 12, p1523 

    This study examined the safety and efficacy of an escalating dose (100?mg, 200?mg, 400?mg/day) of American ginseng over 6 weeks in a single-center, randomized, double-blind, placebo-controlled, crossover trial with 56 subjects with multiple sclerosis and fatigue. There were no serious adverse...

  • New Research, Hope for MS Patients. V.D. // Access;Nov2001, Vol. 15 Issue 9, p10 

    Reports on various avenues of medical research explored in managing patients with multiple sclerosis. Possible connection of hormones in the recovery of women with multiple sclerosis; Process of degeneration of the myelin sheath of the central nervous system resulting from multiple sclerosis;...

  • Epidemiology of Multiple Sclerosis in Western Herzegovina and Herzegovina -- Neretva Canton, Bosnia and Herzegovina. Klupka-Sarić, Inge; Galić, Marijana // Collegium Antropologicum;2010 Supplement 1, Vol. 34, p189 

    The aim of this study was to investigate the selected indicators of multiple sclerosis (MS) in Herzegovina (Western Herzegovina Canton and Herzegovina-Neretva Canton). By using all available health and medical sources in the studied area and using McDonald's criteria, a total of 96 patients were...

  • Defining the natural history of MS: the need for complete data and rigorous definitions. Confavreux, C. // Multiple Sclerosis (13524585);Apr2008, Vol. 14 Issue 3, p289 

    The article reports on the study regarding secondary progressive multiple sclerosis (SPMS) in British Columbia. It found that the median time from an exacerbating-remitting onset of MS to conversion to secondary progression could be estimated using the Kaplan-Meier technique. It also shows that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics